This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WestlakeVillage BioPartners , a brand new venturecapital fund focused on the life sciences, said on Wednesday that it has launched a new, $320 investment fund aimed at early stage companies. According to the new venture fund, it was founded by Beth Seidenberg, M.D.,
WestlakeVillage-based WaveConnex , an early stage startup developing wireless technology based on millimeter-wave, 60Ghz signals, has raised $2.0M The company, which is based on technology developed by UCLA professor Frank Chang, includes the notable involvement of billionaire and Abraxis founder Patrick Soon-Shiong.
Southern California venture totals for Q3 totaled around $1.0 billion in investments, according to the Q3 analysis of venturecapital deals by socalTECH.com. Other big deals included $60M in investment in San Diego's Skinit , a developer of personalized "skins" for electronic devices, and $37.0M billion invested in Q2.
WestlakeVillage-based Cynvenio Biosystems , a developer of high speed, bioseparation instruments for the life sciences market, has raised $1.96M in a Series B funding round, according to a regulatory filing by the firm today. Tags: cynvenio biosystems lifescience venturecapital funding bioseparation.
WestlakeVillage-based Inphi Corp , a developer of high speed analog semiconductors, said today that it has rolled out a new, 40 Gbps component for the optical market. Inphi is venture backed by Cadence Design Systems, Dali-Hook Partners, Flextronics, Mayfield, Tallwood VentureCapital, and Walden International.
WestlakeVillage-based Row 44 , the developer of wireless broadband systems for the commercial aviation industry, is expected to announced today that it has raised another $37M in funding. Tags: row44 wifi wireless broadband aviation commercial venturecapital southwest telecom. The firm is headed by John Guidon.
Row 44 / John Guidon / WestlakeVillage - Guidon sold his last firm--Comcore Semiconductor--back in 1998 to National Semiconductor, for a substantial gain. The firm has backing from such investors as Google Ventures, Bessemer Venture Partners, and OReilly AlphaTech Ventures. Let us know in the comments below!).
WestlakeVillage-based Zumbox , a developer of a system for sending electronic mail to postal addresses, announced today that it has raised $8M in a funding. Zumbox develops a service--aimed at marketers and businesses--to target individuals with electronic mailings, based on their street address, rather than their email inbox.
WestlakeVillage-based Altasens , a developer of CMOS image sensors, has raised $15.1M out of a $20.1M funding round, according to a regulatory filing from the firm Thursday. Details on the funding have not been announced by the company.
WestlakeVillage-based Inphi , a developer of high speed, analog semiconductors, announced today that it has hired on a new VP of Operations, Atul Shingal. Inphi develops high speed analog semiconductors used in the server, storage, and networking markets. READ MORE>>.
A major competitor to WestlakeVillage-based Row 44 , which develops Wi-Fi equipment for the commercial aviation market, has scored a big funding round this morning. Those investors include Ripplewood Holdings, Blumenstein/Thorne Information Partners and other investment entities associated with Oakleigh Thorne.
WestlakeVillage-based warehouse robot developer inVia Robotics, which is led by Lior Elazary, says that it has raised $30M in a Series C funding round. The funding came from Microsoft's venturecapital fund, M12, as well as Qualcomm Ventures, Hitachi Ventures, the corporate venture arm of Hitachi, Ltd.,
Alex Schneider: It all started in 2003, when the city created an economic development fund worth $5M. It was a kind of rainy day fund, available for economic development purposes. We put out an RFQ to all sorts of venturecapital firms in California, in order to be the fiscal steward of that money. . $3M
The funding came from WestlakeVillage BioPartners. ACELYRIN said it is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates. Size of the funding round was not announced. READ MORE>>.
WestlakeVillage-based Specialists On Call , a firm developing a service to provide physician specialists to urban, suburban, and other hospitals via videoconferencing, has raised around $11.73M in a series of fundings, according to regulatory filings by the firm this week.
WestlakeVillage-based Inphi Corporation, which develops high speed analog semiconductors, said Monday that the firm has scored validation from Intel. Inphi is backed by Cadence Design Systems, Dali-Hook Partners, Flextronics, Mayfield, Tallwood VentureCapital, and Walden International.
WestlakeVillage-based Sienna Biopharmaceuticals , a startup biopharmaceuticals firm developing products for the medical dermatology and aesthetics market, has filed for an IPO. Morgan, Cowen, and BMO Capital Markets. Sienna said it is hoping to raised up to $74.8M in an offering on the NASDAQ Global Market.
WestlakeVillage-based Cyber-Rain , a developer of smart irrigation controllers, has raised $792,454 in an equity funding raise, according to a regulatory filing by the firm this week. Cyber-Rain has previously raised funding from Funk Ventures, Momentum Ventures, a various angel investors, including the Tech Coast Angels.
But a new venturecapital firm led by industry veterans is trying to cast the City of Angels in a new light. WestlakeVillage BioPartners is launching today with $350 million in committed capital. Harper will start with Westlake in January after retiring from Amgen.
Two are clinical-stage biotechs: Cambridge, MA-based Black Diamond Therapeutics, which is looking to raise $151 million, and WestlakeVillage, CA-based Arcutis Biotherapeutics, which aims to add $125 million. Cancer drug developer Black Diamond filed IPO paperwork with regulators on Jan.
Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.
WestlakeVillage-based Energy Vault, which is developing gravity-based, grid-scale energy storage systems, has raised $100M in its Series C funding round, the company announced this morning.
WestlakeVillage-based gravity energy storage technology developer Energy Vault announced this morning that it is in a $100M transaction with two companies, Atlas Renewable and China Tianying, which involves a $50M investment subscription and an expansion of a PIPE agreement from $150M to $200M.
Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. Dantari has appointed Richard A.
China also continued its push in biomedicine with regulators there stamping the first approval of a drug discovered and developed in China. This week brought the first sliver of human data from an in-body gene editing procedure, and the results were decidedly undecided (more on that below).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content